6Jerums G,Allen TJ,Campbell DJ,et al.Long-term comparison between perimdopril and nifedipine in normotensive patients with type I diabetes and microalbuminuria[J].Am J Kidney Dis,2006,37(5):890-899.
7Thomas U. Neurohormonal modulation in cardiovascular.Am Heart Journal, 2000,139(NO. 1part 2) :2 - 6.
8Burns KD. Angiotensin II and its receptors in the diabetic kidney. Am J Kidney Dis, 2000,36(3) :449 - 467.
9Burnier M, Brunner HR. Angiotensin II receptor antagonists. The Lancet, 2000,355 : 637 - 645.
10Ccoper ME, Webb RL, de Gasparo M. Angiotensin receptor blockers and the kidney: possible advantages over ACE inhibition? Cardiovas Drug Rev, 2001,19(1) : 75 - 86.
6Scheen AJ.Renin-angiotensin system inhibition prevents type 2 diabetes mellitus part 1,a meta-analysis of randomized clinical trials[J].Diabetes Metab,2004,30(6):487-496.
7Ronquist C,Rodriguez LA,Ruigomez A,et al.Association between captopril other antihypertensive drugs and risk of prostate cancer[J].Prostate,2004,58(1):50-56.
8da Cunha V,Tham DM,Martin-McNulty B,et al.Enalapril attenuates angiotensin Ⅱ induced atherosclerosis and vascular inflammation[J].Atherosclerosis,2005,178(1):9-17.
9Manning J,Vehaskari VM.Postnatal modulation of prenatally programmed hypertension by dietary Na and ACE inhibition[J].Am J Physiol Regul Integr Comp Physiol,2005,288(1):R80.
10Barnett AH.Preventing renal complications in diabetic patients:the diabetics exposed to telmisartan and enalapril (DETAIL) study[J].Acta Diabetol,2005,42(Suppl 1):42-49.
